SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128173	Articles
104823	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 03/28/2025 at 07:05, 10 months 11 days ago

Dupixent Approved in Japan as First Biologic for COPD

Japan Dupixent COPD Treatment Sanofi-Aventis Biologic Approval
PRESS RELEASE

published on 03/28/2025 at 07:00, 10 months 11 days ago

Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Dupixent approved as the first-ever biologic medicine in Japan for COPD patients based on pivotal phase 3 results in adults with elevated eosinophils, marking a new treatment approach for COPD

Japan COPD Dupixent Phase 3 Results Biologic Medicine
PRESS RELEASE

published on 03/24/2025 at 19:27, 10 months 15 days ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 03/24/2025 at 07:35, 10 months 15 days ago

Sanofi launches the “Q1 2025 Aide mémoire” document

Financial Results Investors Sanofi Q1 2025 Memory Aid
PRESS RELEASE

published on 03/24/2025 at 07:30, 10 months 15 days ago

Press Release: Availability of the Q1 2025 Aide mémoire
Sanofi announced the availability of the Q1 2025 Aide mémoire on its website to assist in financial modeling, including non-comparable items and first quarter reminders

Sanofi Financial Modeling Aide Mémoire Q1 2025 Exclusivity Losses
PRESS RELEASE

published on 03/10/2025 at 21:09, 10 months 29 days ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 03/08/2025 at 19:05, 11 months ago

Sanofi-Aventis Reports Positive Data for Dupixent in Bullous Pemphigoid

Clinical Study Dupixent Type 2 Inflammation Bullous Pemphigoid Regulatory Review
PRESS RELEASE

published on 03/08/2025 at 19:00, 11 months ago

Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Positive pivotal data for Dupixent in bullous pemphigoid presented at AAD, showing significant disease remission and reduction in severity, itch, and medication use. Regulatory submissions under review in US and EU

Dupixent Type 2 Inflammation Bullous Pemphigoid AAD Sustained Remission
BRIEF

published on 02/25/2025 at 07:05, 11 months 11 days ago

Sarclisa Gains Approval in Japan for Multiple Myeloma Treatment

Multiple Myeloma Sarclisa Approval Sanofi Oncology Japan Healthcare IMROZ Study
PRESS RELEASE

published on 02/25/2025 at 07:00, 11 months 11 days ago

Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
Sarclisa approved in Japan for newly diagnosed multiple myeloma patients, offering new treatment options based on positive IMROZ phase 3 study results

Oncology Japan Multiple Myeloma Sarclisa IMROZ Study

Accesswire

Published on 02/08/2026 at 21:00, 2 hours 18 minutes ago

Banyan Gold Extends Airstrip and High-Grade Mineralization to 350m Vertical Depth, Yukon, Canada
Published on 02/07/2026 at 01:00, 1 day 22 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 2 days ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 2 days 1 hour ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 2 days 7 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 1 day 2 hours ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 1 day 6 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 1 day 6 hours ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 2 days 3 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 2 days 5 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 2 days 4 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 days 7 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 3 days 3 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 3 days 4 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 3 days 5 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE